Result of EGM

Summary by AI ^BETAClose X

Ceiba Investments Limited announced the result of its extraordinary general meeting held on April 14, 2026, where a resolution to grant authority to issue new ordinary shares and disapply pre-emption rights was passed with 18,913,961 votes in favour and zero against, representing 100% of the votes cast. Proxy appointments were made in respect of 18,979,961 ordinary shares, which is 14% of the total issued ordinary shares, with 66,000 votes withheld. This shareholder approval allows the company to issue new shares, which could impact the share price through potential dilution or capital raising activities.

Disclaimer*

Ceiba Investments Limited

14 April 2026

CEIBA INVESTMENTS LIMITED

(the "Company")

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

RESULT OF EXTRAORDINARY GENERAL MEETING

The Company advises that for the extraordinary general meeting held on 14 April 2026 valid proxy appointments were made in respect of 18,979,961 ordinary shares of the Company in issue, being 14% of the total ordinary shares of the Company in issue, and the resolution was passed.

The full voting result was as follows: -

Extraordinary Resolution		For		Against		TOTAL VOTES CAST	Votes withheld
Extraordinary Resolution		No. of Votes	%	No of Votes	%	No. of votes	No. of votes
1	Grant authority to issue new ordinary shares and disapply pre-emption rights	18,913,961	100	-	-	18,913,961	66,000

For further information, please contact:

Sebastiaan Berger

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Patrick Weaver (Corporate Finance)

Sam Greatrex (Sales)

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

www.ceibainvestments.co.uk

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END